Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award No cap on annual assistance · Income Income-based eligibility; threshold not published · Copays, coinsurance, deductibles, health insurance premiums
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
C00.0 C01 C02.0 C03.0 C04.0 C09.0 C10.0 C13.0 C14.0 C15.5 C15.9 C16.0 C16.1 C16.2 C16.9 C18.0 C18.9 C19 C20 C22 C22.0 C24.0 C24.9 C34.00 C34.10 C34.30 C34.90 C34.91 C34.92 C43.0 C43.10 C43.20 C43.30 C43.51 C43.59 C43.71 C43.72 C43.9 C44.40 C45.0 C45.9 C48.1 C49.0 C49.9 C50.011 C50.111 C50.911 C53.0 C53.9 C54.1 C56.9 C57.00 C64.1 C64.9 C67.0 C67.9 C71.9 C81.00 C81.10 C81.20 C81.30 C81.40 C81.70 C81.90Drugs whose J-codes this fund matches. Each links to its billing & coding reference.
Run a Medicare estimate for a covered drug in about a minute. The fund's award caps against the patient share CareCost calculates.
As of June 3, 2026, the The Assistance Fund Hepatocellular Carcinoma (HCC) fund is OPEN and accepting applications. Verify at time of service: 855-228-9972.
No cap on annual assistance. Copays, coinsurance, deductibles, health insurance premiums
Household income must be Income-based eligibility; threshold not published. US residents and Puerto Rico.
Accepted: commercial, medicare, medicaid.